Form 8-K - Current report:
SEC Accession No. 0000950170-24-132883
Filing Date
2024-12-03
Accepted
2024-12-03 17:20:34
Documents
11
Period of Report
2024-12-03
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K trvi-20241203.htm   iXBRL 8-K 81917
  Complete submission text file 0000950170-24-132883.txt   205632

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT trvi-20241203.xsd EX-101.SCH 28464
13 EXTRACTED XBRL INSTANCE DOCUMENT trvi-20241203_htm.xml XML 4888
Mailing Address 195 CHURCH STREET 14TH FLOOR NEW HAVEN CT 06510
Business Address 195 CHURCH STREET 14TH FLOOR NEW HAVEN CT 06510 203-304-2499
Trevi Therapeutics, Inc. (Filer) CIK: 0001563880 (see all company filings)

EIN.: 450834299 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38886 | Film No.: 241523758
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)